Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,104,451
-
Total 13F shares
-
90,529,530
-
Share change
-
-3,578,068
-
Total reported value
-
$480,755,771
-
Put/Call ratio
-
3.1%
-
Price per share
-
$5.31
-
Number of holders
-
216
-
Value change
-
-$73,903,588
-
Number of buys
-
129
-
Number of sells
-
104
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q2 2025
As of 30 Jun 2025 MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) had 216 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 90,529,530 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, GLENVIEW CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, and Qube Research & Technologies Ltd.
This table shows 217 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.